BridgeBio Pharma - 7 Year Stock Price History | BBIO
Historical daily share price chart and data for BridgeBio Pharma since 2019 adjusted for splits and dividends. The latest closing stock price for BridgeBio Pharma as of September 17, 2026 is 67.31.
- The all-time high BridgeBio Pharma stock closing price was 90.17 on July 09, 2026.
- The BridgeBio Pharma 52-week high stock price is 93.42, which is 38.8% above the current share price.
- The BridgeBio Pharma 52-week low stock price is 48.78, which is 27.5% below the current share price.
- The average BridgeBio Pharma stock price for the last 52 weeks is 71.11.
| BridgeBio Pharma Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 73.8741 | 78.2350 | 90.1700 | 63.7300 | 67.3100 | -12.00% |
| 2025 | 46.4026 | 28.2000 | 77.0900 | 28.1200 | 76.4900 | 178.75% |
| 2024 | 28.2981 | 40.4500 | 40.4500 | 22.3500 | 27.4400 | -32.03% |
| 2023 | 21.3429 | 7.1700 | 43.8900 | 7.1700 | 40.3700 | 429.79% |
| 2022 | 9.6533 | 17.1600 | 17.1600 | 5.2100 | 7.6200 | -54.32% |
| 2021 | 54.4717 | 63.6400 | 72.3500 | 11.3800 | 16.6800 | -76.54% |
| 2020 | 35.3458 | 33.2200 | 71.1100 | 16.1100 | 71.1100 | 102.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $13.352B | $0.502B |
| BridgeBio Pharma Inc. is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio Pharma Inc. is based in PALO ALTO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Aspen Pharmacare (APNHY) | South Africa | $4.248B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Bausch Health Cos (BHC) | Canada | $2.129B | 1.33 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.043B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |